Northwestern University researchers have successfully coaxed a deadly pathogen to destroy itself from the inside out.
FDA grants Enhertu tumor-agnostic accelerated approval
The FDA on Friday gave Daiichi Sankyo and AstraZeneca’s antibody-drug conjugate Enhertu a tumor-agnostic indication under accelerated approval. It’s the first such approval for a